The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment
Abstract
Through the success of basic and disease-specific research, cancer survivors are one of the largest growing subsets of individuals accessing the healthcare system. Interestingly, cardiovascular disease is the second leading cause of morbidity and mortality in cancer survivors after recurrent malignancy. This recognition has helped stimulate a collaboration between oncology and cardiology practitioners and researchers, and the portmanteau cardio-oncology (also known as onco-cardiology) can now be found in many medical centers. This collaboration promises new insights into how cancer therapies impact cardiovascular homeostasis and long-term effects on cancer survivors. In this review, we will discuss the most recent views on the cardiotoxicity related to various classes of chemotherapy agents and radiation. We will also discuss broadly the current strategies for treating and preventing cardiovascular effects of cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,723
Smith, I., Procter, M., Gelber, R. D., Guillaume, S., Feyereislova, A., Dowsett, M., Goldhirsch, A., Untch, M., Mariani, G., Baselga, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60028-2 · Cited by 1,507
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,313
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Anthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
Darby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Cardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,026
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Scappaticci, F. A., Skillings, J. R., Holden, S. N., Gerber, H.-P., Miller, K., Kabbinavar, F., Bergsland, E., Ngai, J., Holmgren, E., Wang, J., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm086 · Cited by 938
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
Curigliano, G., Cardinale, D., Suter, T., Plataniotis, G., de Azambuja, E., Sandri, M. T., Criscitiello, C., Goldhirsch, A., Cipolla, C., & Roila, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds293 · Cited by 865
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer
Hooning, M. J., Botma, A., Aleman, B. M. P., Baaijens, M. H. A., Bartelink, H., Klijn, J. G. M., Taylor, C. W., & van Leeuwen, F. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk064 · Cited by 861
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00008 · Cited by 749
Late cardiotoxicity after treatment for Hodgkin lymphoma
Aleman, B. M. P., van den Belt-Dusebout, A. W., De Bruin, M. L., van 't Veer, M. B., Baaijens, M. H. A., Boer, J. P. D., Hart, A. A. M., Klokman, W. J., Kuenen, M. A., Ouwens, G. M., et al. (2007) · Blood · doi:10.1182/blood-2006-07-034405 · Cited by 746
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Ewer, M. S., Vooletich, M. T., Durand, J.-B., Woods, M. L., Davis, J. R., Valero, V., & Lenihan, D. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.300 · Cited by 726
Clinical toxicities encountered with paclitaxel (Taxol).
Rowinsky, E. K., Eisenhauer, E. A., Chaudhry, V., Sg, A., & Rc, D. (1993) · PubMed · Cited by 692
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Cohen, V., Gosavi, S., Carver, J. R., Wiegers, S. E., Martin, R. P., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.006 · Cited by 682
Prevention of Anthracycline-Induced Cardiotoxicity
Vejpongsa, P., & Yeh, E. T. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1167 · Cited by 671
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
Swain, S. M., Whaley, F. S., Gerber, M. C., Weisberg, S., York, M., Spicer, D., Jones, S. E., Wadler, S., Desai, A., Vogel, C., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1318 · Cited by 664
Use of Statins and the Risk of Death in Patients With Prostate Cancer
Yu, O., Eberg, M., Benayoun, S., Aprikian, A., Batist, G., Suissa, S., & Azoulay, L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.4757 · Cited by 659
Bosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales-Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632
Lyu, Y. L., Kerrigan, J. E., Lin, C.-P., Azarova, A. M., Tsai, Y.-C., Ban, Y., & Liu, L. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1649 · Cited by 612
Trastuzumab containing regimens for early breast cancer
Moja, L., Tagliabue, L., Balduzzi, S., Parmelli, E., Pistotti, V., Guarneri, V., & D'Amico, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006243.pub2 · Cited by 604
Schneider, B. P., Wang, M., Radovich, M., Sledge, G. W., Badve, S., Thor, A., Flockhart, D. A., Hancock, B., Davidson, N., Gralow, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1612 · Cited by 604
Ky, B., Putt, M., Sawaya, H., French, B., Januzzi, J. L., Sebag, I. A., Plana, J. C., Cohen, V., Banchs, J., Carver, J. R., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.061 · Cited by 563
Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer
Giordano, S. H., Kuo, Y.-F., Freeman, J. L., Buchholz, T. A., Hortobagyi, G. N., & Goodwin, J. S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji067 · Cited by 552
Harris, L., Batist, G., Belt, R., Rovira, D., Navari, R., Azarnia, N., Welles, L., Winer, E., & TLC D‐99 Study Group (2002) · Cancer · doi:10.1002/cncr.10201 · Cited by 512
Radiation-associated cardiovascular disease
Adams, M. J., Hardenbergh, P. H., Constine, L. S., & Lipshultz, S. E. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00227-x · Cited by 506
Vascular Endothelial Growth Factors
Ylä-Herttuala, S., Rissanen, T. T., Vajanto, I., & Hartikainen, J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.053 · Cited by 480
Robert, N., Leyland-Jones, B., Asmar, L., Belt, R., Ilegbodu, D., Loesch, D., Raju, R., Valentine, E., Sayre, R., Cobleigh, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1764 · Cited by 479
Brosius, F. C., Waller, B. F., & Roberts, W. C. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90574-x · Cited by 473
McGale, P., Darby, S. C., Hall, P., Adolfsson, J., Bengtsson, N.-O., Bennet, A. M., Fornander, T., Gigante, B., Jensen, M.-B., Peto, R., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.016 · Cited by 459
Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T., Kerkhoven, R., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 420
Haugnes, H. S., Wethal, T., Aass, N., Dahl, O., Klepp, O., Langberg, C. W., Wilsgaard, T., Bremnes, R. M., & Fosså, S. D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.9362 · Cited by 404
Stewart, J. R., Fajardo, L. F., Gillette, S. M., & Constine, L. S. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00656-6 · Cited by 403
Bovelli, D., Plataniotis, G., & Roila, F. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq200 · Cited by 401
Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases
VEINOT, J. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90447-5 · Cited by 385
Trastuzumab-Related Cardiotoxicity: Calling Into Question the Concept of Reversibility
Telli, M. L., Hunt, S. A., Carlson, R. W., & Guardino, A. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0106 · Cited by 385
Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
Abal, M., Andreu, J., & Barasoain, I. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481967 · Cited by 383
Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer
van den Belt-Dusebout, A. W., Nuver, J., de Wit, R., Gietema, J. A., ten Bokkel Huinink, W. W., Rodrigus, P. T. R., Schimmel, E. C., Aleman, B. M. P., & van Leeuwen, F. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7193 · Cited by 345
VEGF-A: a critical regulator of blood vessel growth
Ferrara, N. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0170 · Cited by 327
Izumiya, Y., Shiojima, I., Sato, K., Sawyer, D. B., Colucci, W. S., & Walsh, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000215207.54689.31 · Cited by 326
Self-citationAminkeng, F., Bhavsar, A. P., Visscher, H., Rassekh, S. R., Li, Y., Lee, J. W., Brunham, L. R., Caron, H. N., van Dalen, E. C., Kremer, L. C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3374 · Cited by 278
De Angelis, A., Piegari, E., Cappetta, D., Marino, L., Filippelli, A., Berrino, L., Ferreira-Martins, J., Zheng, H., Hosoda, T., Rota, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.895771 · Cited by 268
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
Polk, A., Vistisen, K., Vaage-Nilsen, M., & Nielsen, D. L. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-47 · Cited by 267
Horowitz, J. R., Rivard, A., van der Zee, R., Hariawala, M., Sheriff, D. D., Esakof, D. D., Chaudhry, G. M., Symes, J. F., & Isner, J. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2793 · Cited by 266
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
van Dalen, E. C., Michiels, E. M. C., Caron, H. N., & Kremer, L. C. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005006.pub4 · Cited by 265
Galper, S. L., Yu, J. B., Mauch, P. M., Strasser, J. F., Silver, B., LaCasce, A., Marcus, K. J., Stevenson, M. A., Chen, M. H., & Ng, A. K. (2011) · Blood · doi:10.1182/blood-2010-06-291328 · Cited by 253
Heart failure associated with sunitinib malate: A multitargeted receptor tyrosine kinase inhibitor
Khakoo, A. Y., Kassiotis, C. M., Tannir, N., Plana, J. C., Halushka, M., Bickford, C., Trent, J., Champion, J. C., Durand, J., & Lenihan, D. J. (2008) · Cancer · doi:10.1002/cncr.23460 · Cited by 252
Radiation-Induced Heart Disease: A Study of Twenty-five Patients
Stewart, J. R., Cohn, K. E., Fajardo, L. F., Hancock, E. W., & Kaplan, H. S. (1967) · Radiology · doi:10.1148/89.2.302 · Cited by 244
U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
Herndon, T. M., Deisseroth, A., Kaminskas, E., Kane, R. C., Koti, K. M., Rothmann, M. D., Habtemariam, B., Bullock, J., Bray, J. D., Hawes, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0755 · Cited by 241
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
Telli, M. L., Witteles, R. M., Fisher, G. A., & Srinivas, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn168 · Cited by 237
Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention
Horenstein, M. S., Vander Heide, R. S., & L'Ecuyer, T. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3043 · Cited by 228
Vejpongsa, P., & Yeh, E. T. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.201 · Cited by 225
Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer
Patt, D. A., Goodwin, J. S., Kuo, Y.-F., Freeman, J. L., Zhang, D. D., Buchholz, T. A., Hortobagyi, G. N., & Giordano, S. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.755 · Cited by 225
Dahlberg, S. E., Sandler, A. B., Brahmer, J. R., Schiller, J. H., & Johnson, D. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4482 · Cited by 223
Sardaro, A., Petruzzelli, M. F., D’Errico, M. P., Grimaldi, L., Pili, G., & Portaluri, M. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.02.008 · Cited by 220
Hall, P. S., Harshman, L. C., Srinivas, S., & Witteles, R. M. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.09.001 · Cited by 207
Huang, C., Zhang, X., Ramil, J. M., Rikka, S., Kim, L., Lee, Y., Gude, N. A., Thistlethwaite, P. A., Sussman, M. A., Gottlieb, R. A., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.902221 · Cited by 203
Russell, S. D., Blackwell, K. L., Lawrence, J., Pippen, J. E., Roe, M. T., Wood, F., Paton, V., Holmgren, E., & Mahaffey, K. W. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6950 · Cited by 200
Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults
Larsen, R. L., Jakacki, R. I., Vetter, V. L., Meadows, A. T., Silber, J. H., & Barber, G. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91393-i · Cited by 197
Radiation-Associated Valvular Disease*
Carlson, R. G., Mayfield, W. R., Normann, S., & Alexander, J. A. (1991) · Chest · doi:10.1378/chest.99.3.538 · Cited by 194
Poklar, N., Pilch, D. S., Lippard, S. J., Redding, E. A., Dunham, S. U., & Breslauer, K. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7606 · Cited by 191
Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage
Geisberg, C. A., & Sawyer, D. B. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0146-y · Cited by 189
Self-citationUnderstanding Radiation-Induced Vascular Disease
Weintraub, N. L., Jones, W. K., & Manka, D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.053 · Cited by 187
Unexpected cardiotoxicity in haematological bortezomib treated patients
Orciuolo, E., Buda, G., Cecconi, N., Galimberti, S., Versari, D., Cervetti, G., Salvetti, A., & Petrini, M. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06659.x · Cited by 185
Richards, C. J., Je, Y., Schutz, F. A. B., Heng, D. Y. C., Dallabrida, S. M., Moslehi, J. J., & Choueiri, T. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4309 · Cited by 180
Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
Cardinale, D., & Sandri, M. T. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.04.002 · Cited by 168
The ubiquitin–proteasome system in cardiac dysfunction
Mearini, G., Schlossarek, S., Willis, M. S., & Carrier, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.009 · Cited by 167
Prone vs Supine Positioning for Breast Cancer Radiotherapy
Formenti, S. C., DeWyngaert, J. K., Jozsef, G., & Goldberg, J. D. (2012) · JAMA · doi:10.1001/2012.jama.10759 · Cited by 164
The role of Neuregulin-1β/ErbB signaling in the heart
Pentassuglia, L., & Sawyer, D. B. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.08.015 · Cited by 162
Self-citationCardiac safety of liposomal anthracyclines
Ewer, M. S., Martin, F. J., Henderson, I. C., Shapiro, C. L., Benjamin, R. S., & Gabizon, A. A. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.006 · Cited by 160
Mackey, J. R., Clemons, M. J., Côté, M. A., Delgado, D., Dent, S. F., Paterson, A., Provencher, L., Sawyer, M. B., & Verma, S. (2008) · Current Oncology · doi:10.3747/co.2008.199 · Cited by 154
Radiation induced heart disease
Heidenreich, P. A., & Kapoor, J. R. (2009) · Heart · doi:10.1136/hrt.2008.149088 · Cited by 149
Nuver, J., Smit, A. J., Sleijfer, D. T., van Gessel, A. I., van Roon, A. M., van der Meer, J., van den Berg, M. P., Burgerhof, J. G. M., Hoekstra, H. J., Sluiter, W. J., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.012 · Cited by 149
Advani, A., Kelly, D. J., Advani, S. L., Cox, A. J., Thai, K., Zhang, Y., White, K., Gow, R. M., Marshall, S. M., Steer, B. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703577104 · Cited by 145
RADIATION-INDUCED HEART DISEASE
Stewart, J. R., & Fajardo, L. F. (1971) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)01790-0 · Cited by 144
Radiation-induced heart disease. Clinical and experimental aspects.
Stewart, J. R., & Fajardo, L. F. (1971) · PubMed · Cited by 138
Perez, E. A., Suman, V. J., Rowland, K. M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.047 · Cited by 137
Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors
Ghatalia, P., Morgan, C. J., Je, Y., Nguyen, P. L., Trinh, Q., Choueiri, T. K., & Sonpavde, G. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.12.008 · Cited by 133
Cerebrovascular disease in childhood cancer survivors
Morris, B., Partap, S., Yeom, K. W., Gibbs, I. C., Fisher, P. G., & King, A. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c17ea8 · Cited by 127
Onitilo, A. A., Engel, J. M., & Stankowski, R. V. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614529603 · Cited by 124
Green, D. M., Hyland, A. J., Chung, C. S., Zevon, M. A., & Hall, B. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3207 · Cited by 121
Oliveira, G. H., Dupont, M., Naftel, D. C., Myers, S. L., Yuan, Y., Tang, W. H. W., Gonzalez‐Stawinski, G. V., Young, J. B., Taylor, D. O., & Starling, R. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.040 · Cited by 119
Ma, H., Jones, K. R., Guo, R., Xu, P., Shen, Y., & Ren, J. T. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05323.x · Cited by 116
Scotland, R. S., Morales‐Ruiz, M., Chen, Y., Yu, J., Rudic, R. D., Fulton, D. J., Gratton, J., & Sessa, W. C. (2002) · Circulation Research · doi:10.1161/01.res.0000016506.04193.96 · Cited by 110
Long-term platinum retention after treatment with cisplatin and oxaliplatin
Brouwers, E. E. M., Huitema, A. D. R., Beijnen, J. H., & Schellens, J. H. M. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-7 · Cited by 107
Singh, J. C., Jhaveri, K. L., & Esteva, F. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.388 · Cited by 107
Groarke, J. D., Tanguturi, V. K., Hainer, J. M., Klein, J., Moslehi, J. J., Ng, A. K., Forman, D. E., Carli, M. F. D., & Nohria, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.035 · Cited by 99
Radiation-induced heart disease
Sharma, R. (2017) · Radiopaedia.org · doi:10.53347/rid-57485 · Cited by 95
Pentassuglia, L., Timolati, F., Seifriz, F., Kaisaier, A., Suter, T. M., & Zuppinger, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.02.007 · Cited by 85
Heart Transplant Survival Outcomes for Adriamycin-Dilated Cardiomyopathy
Lenneman, A., Wang, L. A., Wigger, M., Frangoul, H., Harrell, F. E., Silverstein, C. A., Sawyer, D. B., & Lenneman, C. G. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.048 · Cited by 80
Self-citationGenotyping the risk of anthracycline-induced cardiotoxicity
Deng, S., & Wojnowski, L. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0024-2 · Cited by 79
Nuver, J., de Haas, E. C., van Zweeden, M., Gietema, J. A., & Meijer, C. (2010) · PubMed · Cited by 77
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
van Dalen, E. C., Michiels, E. M. C., Caron, H. N., & Kremer, L. C. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005006.pub3 · Cited by 72
Bortezomib is an efficient agent in plasma cell leukemias
Esparís‐Ogando, A., Alegre, A., Aguado, B., Mateo, G., Gutiérrez, N., Bladé, J., Schenkein, D., Pandiella, A., & San Miguel, J. F. (2005) · International Journal of Cancer · doi:10.1002/ijc.20793 · Cited by 70
Late Cardiovascular Toxicity Following Chemotherapy for Germ Cell Tumors
Feldman, D. R., Schaffer, W. L., & Steingart, R. M. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0051 · Cited by 69
Howarth, F. C., Calaghan, S. C., Boyett, M. R., & White, E. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0409v.x · Cited by 68
Giordano, S. H., Booser, D. J., Murray, J. L., Ibrahim, N. K., Rahman, Z. U., Valero, V., Theriault, R. L., Rosales, M., Rivera, E., Frye, D. K., et al. (2002) · PubMed · Cited by 65
Experimental Radiation-Induced Heart Disease: Past, Present, and Future
Boerma, M. (2012) · Radiation Research · doi:10.1667/rr2933.1 · Cited by 54
Advanced Heart Failure Therapies for Patients With Chemotherapy-Induced Cardiomyopathy
Oliveira, G. H., Qattan, M. Y., Al-Kindi, S. G., & Park, S. J. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001292 · Cited by 52
Yun, S., Vincelette, N. D., & Abraham, I. L. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133535 · Cited by 52
Geisberg, C. A., Abdallah, W. M., da Silva, M., Silverstein, C. A., Smith, H., Abramson, V. G., Mayer, I. A., Means-Powell, J. A., Freehardt, D., White, B. W., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.11.006 · Cited by 45
Self-citationKuramochi, Y., Lim, C. C., Guo, X., Colucci, W. S., Liao, R., & Sawyer, D. B. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00312.2003 · Cited by 41
Self-citationMcCaffrey, T. A., Tziros, C., Lewis, J. F., et al. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6058 · Cited by 30
Patel, D., Bassi, R., Hooper, A. T., Sun, H., Huber, J., Hicklin, D. J., & Kang, X. (2008) · PubMed · Cited by 23
de Haas, E. C., Zwart, N., Meijer, C., Suurmeijer, A. J. H., Meijer, K., Guchelaar, H., Hoekstra, H. J., van Leeuwen, F. E., Sleijfer, D. T., Boezen, H. M., et al. (2010) · Cancer · doi:10.1002/cncr.25300 · Cited by 22
Unravelling the Causes of Reduced Peak Oxygen Consumption in Patients With Cancer
Koelwyn, G. J., Jones, L. W., & Moslehi, J. J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.949 · Cited by 22
Meijer (2009) · Oncology Reports · doi:10.3892/or_00000630 · Cited by 20
Lenneman, C. G., Abdallah, W. M., Smith, H., Abramson, V. G., Mayer, I. A., Silverstein, C. A., Silverstein, C. A., Means-Powell, J. A., Paranjape, S. Y., Lenihan, D. J., et al. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.446 · Cited by 16
Self-citationCoronary Artery Disease and Breast Radiation Therapy
Pezner, R. D. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.04.046 · Cited by 14
Ge, P. (1997) · PubMed · Cited by 9
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
Metadata
- Authors
- Lenneman, C. G., & Sawyer, D. B.
- Venue
- Circulation Research
- Published
- 2016-03-18
- Volume
- 118
- Issue
- 6
- Pages
- 1008-1020
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2296878578
- Cited by
- 469
- References
- 125
- FWCI
- 20.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.